tetano
Editor, Senior Moderator
Cureus
. 2022 Jul 5;14(7):e26580.
doi: 10.7759/cureus.26580. eCollection 2022 Jul.
Diabetic Ketoacidosis and COVID-19: A Case Series From an Inner-City Community Teaching Hospital in New York
Sowmya Boddhula[SUP] 1 [/SUP], Satish Kumar Boddhula[SUP] 2 [/SUP], Pavani Reddy Garlapati[SUP] 3 [/SUP], Meet J Patel[SUP] 3 [/SUP], Sunday Ekanem[SUP] 3 [/SUP], Sreedhar Adapa[SUP] 4 [/SUP], Vincent Fong[SUP] 5 [/SUP], Swetha Balaji[SUP] 6 [/SUP], Swetha Murthi[SUP] 7 [/SUP], Vijay Gayam[SUP] 3 [/SUP]
Affiliations
Abstract
Introduction: Throughout the coronavirus disease 2019 (COVID-19) pandemic, studies have repeatedly shown that COVID-19 outcomes are more severe in the elderly and those with comorbidities, with diabetes being a significant risk factor associated with more severe infection. Here, we present the clinical characteristics of 25 patients with pre-existing type 2 diabetes mellitus who presented with diabetic ketoacidosis (DKA) and COVID-19 in a community hospital in Brooklyn, New York, and identify possible predictors of mortality.
Methods: This retrospective case series recruited patients from March 1st to April 9th, 2020, with lab-confirmed COVID-19 and met DKA criteria on admission (based on American Diabetes Association diagnostic criteria for DKA).
Results: Of the 25 patients who met the inclusion criteria, 22 were African American and three were Hispanic. Common comorbidities in addition to diabetes were hypertension, obesity, coronary artery disease, and dyslipidemia. Fever, cough, myalgias, and shortness of breath were common presenting symptoms. Most patients had elevated inflammatory markers erythrocyte sedimentation rate, C-reactive protein, D-dimer, and ferritin, but higher values increased the odds of mortality. The overall survival was 64%, with those recovering having more extended hospital stays but requiring less time in the intensive care unit. At the same time, those who died were more likely to require mechanical ventilation, have an acute cardiac injury, and/or be obese. Despite numerous studies on COVID and diabetes, only a few studies described DKA.
Conclusion: This observational retrospective study illustrated that patients with diabetes are at risk of developing DKA with COVID-19 and identified some predictors of mortality. However, further studies with larger sample sizes and a control group are necessary to understand better the effects of COVID-19 on DKA and their clinical outcomes.
Keywords: covid-19; diabetes mellitus; dka; inflammatory markers; kpd.
. 2022 Jul 5;14(7):e26580.
doi: 10.7759/cureus.26580. eCollection 2022 Jul.
Diabetic Ketoacidosis and COVID-19: A Case Series From an Inner-City Community Teaching Hospital in New York
Sowmya Boddhula[SUP] 1 [/SUP], Satish Kumar Boddhula[SUP] 2 [/SUP], Pavani Reddy Garlapati[SUP] 3 [/SUP], Meet J Patel[SUP] 3 [/SUP], Sunday Ekanem[SUP] 3 [/SUP], Sreedhar Adapa[SUP] 4 [/SUP], Vincent Fong[SUP] 5 [/SUP], Swetha Balaji[SUP] 6 [/SUP], Swetha Murthi[SUP] 7 [/SUP], Vijay Gayam[SUP] 3 [/SUP]
Affiliations
- PMID: 35936183
- PMCID: PMC9351819
- DOI: 10.7759/cureus.26580
Abstract
Introduction: Throughout the coronavirus disease 2019 (COVID-19) pandemic, studies have repeatedly shown that COVID-19 outcomes are more severe in the elderly and those with comorbidities, with diabetes being a significant risk factor associated with more severe infection. Here, we present the clinical characteristics of 25 patients with pre-existing type 2 diabetes mellitus who presented with diabetic ketoacidosis (DKA) and COVID-19 in a community hospital in Brooklyn, New York, and identify possible predictors of mortality.
Methods: This retrospective case series recruited patients from March 1st to April 9th, 2020, with lab-confirmed COVID-19 and met DKA criteria on admission (based on American Diabetes Association diagnostic criteria for DKA).
Results: Of the 25 patients who met the inclusion criteria, 22 were African American and three were Hispanic. Common comorbidities in addition to diabetes were hypertension, obesity, coronary artery disease, and dyslipidemia. Fever, cough, myalgias, and shortness of breath were common presenting symptoms. Most patients had elevated inflammatory markers erythrocyte sedimentation rate, C-reactive protein, D-dimer, and ferritin, but higher values increased the odds of mortality. The overall survival was 64%, with those recovering having more extended hospital stays but requiring less time in the intensive care unit. At the same time, those who died were more likely to require mechanical ventilation, have an acute cardiac injury, and/or be obese. Despite numerous studies on COVID and diabetes, only a few studies described DKA.
Conclusion: This observational retrospective study illustrated that patients with diabetes are at risk of developing DKA with COVID-19 and identified some predictors of mortality. However, further studies with larger sample sizes and a control group are necessary to understand better the effects of COVID-19 on DKA and their clinical outcomes.
Keywords: covid-19; diabetes mellitus; dka; inflammatory markers; kpd.